首页> 美国卫生研究院文献>BMC Cancer >Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis

【2h】

Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis

机译：血清抗酒石酸酸性磷酸酶5b活性作为乳腺癌骨转移生存的预后指标

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSerum tartrate-resistant acid phosphatase 5b (TRACP 5b) activity is a marker of osteoclast number and is elevated in breast cancer (BC) patients with extensive bone metastasis, which might in turn reflect the tumour burden. We tested the hypothesis that baseline serum TRACP 5b activity and its interval change are potential prognostic markers of survival in BC patients with bone metastasis.

机译：背景抗酒石酸血清酸性磷酸酶5b（TRACP 5b）的活性是破骨细胞数量的标志，在具有广泛骨转移的乳腺癌（BC）患者中升高，可能反过来反映了肿瘤的负担。我们检验了以下假设：基线血清TRACP 5b活性及其间隔变化是BC骨转移患者生存的潜在预后标志。

著录项

期刊名称 BMC Cancer
作者
Yi-Ying Wu; Anthony J Janckila; Chih-Hung Ku; Cheng-Ping Yu; Jyh-Cherng Yu; Su-Hui Lee; Hsin-Yi Liu; Lung T Yam; Tsu-Yi Chao;
展开▼
作者单位

展开▼
年(卷),期 2010(10),-1
年度 2010
页码 158
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis [J] . Yi-Ying Wu, Anthony J Janckila, Chih-Hung Ku, BMC Cancer . 2010,第1期

机译：血清抗酒石酸酸性磷酸酶5b活性作为乳腺癌骨转移生存的预后指标
2. Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP [J] . B. K. D. Sarvari, D. Sankara Mahadev, S. Rupa, Indian journal of clinical biochemistry: IJCB . 2015,第1期

机译：血清抗酒石酸酸性磷酸酶5b（TRACP 5b），骨吸收标记物和血清碱性磷酸酶（ALP）（一种骨形成标记物）代替Technetium99m MDP
3. Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP [J] . S. A. Mastan, S. Rupa, D. Sankara Mahadev, Indian journal of clinical biochemistry . 2015,第1期

机译：血清抗酒石酸酸性磷酸酶5b（TRACP 5b），骨吸收标记物和血清碱性磷酸酶（ALP）（一种骨形成标记物）替代Technetium99m的全身骨骼扫描，可检测乳腺癌（BC）患者的骨转移MDP
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Genetic variation and protein expression of metastasis-related genes as markers of tumor aggressiveness, recurrence, and survival among breast cancer patients. [D] . Roberts, Michelle R. 2016

机译：转移相关基因的遗传变异和蛋白质表达是乳腺癌患者肿瘤侵袭性，复发和生存的标志。
6. Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b) a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP) a Bone Formation Marker in Lieu of Whole Body Skeletal Scintigraphy with Technetium99m MDP [O] . B. K. D. Sarvari, D. Sankara Mahadev, S. Rupa, 2015

机译：血清抗酒石酸酸性磷酸酶5b（TRACP 5b）骨吸收标志物和血清碱性磷酸酶（ALP）（一种骨形成标志物）代替Technetium99m MDP
7. Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis [O] . Yi-Ying Wu, Anthony J Janckila, Chih-Hung Ku, 2010

机译：血清抗酒石酸酸性磷酸酶5b活性作为乳腺癌骨转移生存的预后指标

Serum tartrate-resistant acid phosphatase 5b activity as a prognostic marker of survival in breast cancer with bone metastasis

摘要

著录项

相似文献

相关主题

期刊订阅